Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2025-12.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 100 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 101
1Department of Biochemistry and Molecular Biology, Integrated Genomic Research Center for Metabolic Regulation, Institute of Genetic Science, Yonsei University College of Medicine, Seoul, Korea.
2Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Korea.
3Department of Integrated OMICS for Biomedical Sciences, Yonsei University Graduate School, Seoul, Korea.
Copyright © 2016 Korean Endocrine Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
GK, glucokinase; PFK, phosphofructokinase; PK, pyruvate kinase; PEPCK, phosphoenol pyruvate carboxykinase; G6Pase, glucose 6-phosphatase; FAS, fatty acid synthase; ACC, acetyl CoA carboxylase; FABP, fatty acid binding protein; FATP, fatty acid transport protein; HK1, hexokinase 1; HK2, hexokinase 2; PDH, pyruvate dehydrogenase; Cyto C, cytochrome C; Glut1, glucose transporter 1; UCP1, uncoupling protein 1; Dio2, deiodinase 2; ELOVL3, elongation of very long chain fatty acid-like 3 (fatty acid elongase 3); Cox8b, cytochrome C oxidase 8b; Prdm16, PR domain containing 16; Ebf2, early B-cell factor 2; Tle3, transducin-like enhancer of split 3; Gsta3, glutathione S-transferase alpha 3; Lyz2, lysozyme C-2 precursor; SREBP, sterol regulatory element-binding protein; PPAR, peroxisome proliferator-activated receptor; PGC, PPAR gamma coactivator; ChREBP, carbohydrate response element-binding protein; LXR, liver X receptor; CREB, cAMP response element-binding protein; 4EBP1, eukaryotic translation initiation factor 4E-binding protein 1; IR, insulin receptor; IRS, insulin receptor substrate; PI3K, phosphoinositol-4,5-bisphosphate 3-kinase; ERK, extracellular signal-regulated kinase; AMPK, 5’ adenosine monophosphate- activated protein kinase; TSC, tuberous sclerosis complex; mTOR, mammalian target of rapamycin; RAPTOR, regulatory-associated protein of mTOR.
RT-PCR, reverse transcriptase-polymerase chain reaction; siRNA, small interfering RNA; shRNA, short hairpin RNA; ELISA, enzyme-linked immunosorbent assay; FACS, fluorescence-activated cell sorting; ChIP, chromatin immunoprecipitation; RNAseq, RNA sequencing; ChIPseq, ChIP sequencing; ATP, adenosine triphosphate; MRI, magnetic resonance imaging; CRISPR/Cas9, clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9; cAMP, cyclic adenosine monophosphate; PER, proboscis extension response; AMPK, 5’ adenosine monophosphate-activated protein kinase.
| 1. Eukaryotic gene structure: promoter, exon, intron, 5´-untranslating region (5´-UTR), 3´-UTR, coding sequence, etc. |
| 2. Gene expression: promoter regulation, codon, transcription factor, transcription, splicing, translation, etc. |
| 3. Protein structure: amino acid sequence, protein domain, protein folding, protein modification (particularly phosphorylation), protein-protein interaction, etc. |
| 4. Gene cloning: recombinant DNA, gene manipulation, vector and plasmid, restriction enzyme, ligation, transformation, competent cells, antibiotic selection, DNA purification, etc. |
| 1. Molecular cloning |
| - Cloning vectors, eukaryotic/prokaryotic expression vectors, plasmid/virus vectors |
| - Enzymes (restriction enzyme, ligase, and other useful enzymes) |
| - Bacterial transformation, competent cells, antibiotic selection |
| - Plasmid DNA purification |
| - DNA sequencing |
| 2. Extraction and preparation of DNA, RNA, and proteins |
| - Extraction of genomic DNA or plasmid DNA |
| - Extraction of total RNA, avoiding degradation |
| - Protein preparation, choosing an optimal lysis buffer based on purpose |
| 3. Molecular detection techniques |
| - Polymerase chain reaction (PCR) and reverse transcriptase-PCR |
| - Real-time PCR |
| - (Agarose) gel electrophoresis, (affinity) chromatography, (ultra) centrifugation |
| - SDS-PAGE and Western blot analysis |
| - Immunoprecipitation |
| - ELISA |
| 4. Manipulation of molecules |
| - Site-directed mutagenesis |
| - siRNA and shRNA technology |
| 5. Introducing molecules |
| - Transfection using chemicals, lipofectamine, virus, and electroporation |
| 6. Handling of experimental models |
| - Cell culture |
| - Animal experiments |
| - Genetically modified mouse model (transgenic or knockout) |
| Model | Frequency, n (%) | Cell lines or animal models |
|---|---|---|
| Cell | 27 (52) | Primary culture, 3T3-L1, HEK293T, NIH-3T3, hiPSC, hESC, adult mouse ear fibroblast, mouse embryonic fibroblast cell, Huh7, A549, H1975, MIN6, IMR-90, MCH46, HK-2 |
| Animal | 47 (90) | Mouse, Drosophila, Caenorhabditis elegans, rat, zebrafish |
| Human | 8 (15) | - |
| Metabolic index | Molecular index |
|---|---|
| Physiologic index: Survival, Body weight, Body Mass Composition, Organ weight/ size, Rectal temperature, Food intake/ energy expenditure, Meal size/number, Feces production, Physical activity | Metabolic enzymes or pathway: GK, PFK, PK, PEPCK, G6Pase, FAS, ACC, FABP, FATP, HK1, HK2, PDH, Lipoprotein, Cyto C, Glut1 |
| Serum index: Fasting/fed glucose, TG/cholesterol, Lipoprotein, Insulin, Glucagon, Fatty acid, Amino acids, ALT/AST, Bile acid, Lactate, Citrate, Fumarate, Succinate, Aspartate, Glutamate, Glutamine, Phosphoenolpyruvate | Thermogenic genes: UCP1, Dio2, ELOVL3, Cidea, Cox8b, Prdm16, Ebf2 |
| White fat-selective genes: Tle3, Resistin, Gsta3, Lyz2 | |
| Brown/beige fat markers: Cited1, Ear2, Tmem26, Hoxa9, Lhx8, Zic1 | |
| Tissue index: Tissue weight, Adipocyte size, Tissue TG content | Transcription pathway: SREBPs, PPARs, PGC, ChREBP, LXR, CREB, 4EBP1 |
| Functional index: Glucose tolerance test (oral/intraperitoneal), Insulin tolerance test, Urinary glucose excretion | Signaling pathway: IR, IRS, PI3K, AKT, ERK, SMAD, AMPK, TSC, mTOR, RAPTOR |
| Category | Techniques (frequency in the articles, out of 52) |
|---|---|
| Basic techniques | Western blot analysis (44) |
| RT-PCR (35) | |
| siRNA or shRNA (10) | |
| ELISA (9) | |
| Immunoprecipitation (7) | |
| FACS (6) | |
| ChIP assay (4) | |
| Screening tools | Metabolomics (9) |
| Proteomics (8) | |
| Microarray (7) | |
| RNAseq (5) | |
| RNA interference screening (2) | |
| ChIPseq (1) | |
| Phosphoproteomics (1) | |
| Metabolism-related or advanced techniques | ATP assay (4) |
| Patch clamp study (3) | |
| Seahorse assay (3) | |
| Echo MRI analysis for fat mass (3) | |
| CRISPR/Cas9 (2) | |
| Thermal imaging (2) | |
| cAMP assay (2) | |
| Indirect calorimetry (2) | |
| Insulin secretion assay (1) | |
| Fatty acid oxidation assay (1) | |
| PER assay in Drosophila (1) | |
| Triglyceride colorimetric assay (1) | |
| Enzymatic colorimetric assay (1) | |
| Luciferase assay (1) | |
| AMPK activity assay (1) | |
| 2-Deoxyglucose uptake assay (1) | |
| Cycling assay (1) |
SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; ELISA, enzyme-linked immunosorbent assay; siRNA, small interfering RNA; shRNA, short hairpin RNA.
HEK293T, human embryonic kidney cells 293 V40 large T antigen; hiPSC, human induced pluripotent stem cell; hESC, human embryonic stem cell.
GK, glucokinase; PFK, phosphofructokinase; PK, pyruvate kinase; PEPCK, phosphoenol pyruvate carboxykinase; G6Pase, glucose 6-phosphatase; FAS, fatty acid synthase; ACC, acetyl CoA carboxylase; FABP, fatty acid binding protein; FATP, fatty acid transport protein; HK1, hexokinase 1; HK2, hexokinase 2; PDH, pyruvate dehydrogenase; Cyto C, cytochrome C; Glut1, glucose transporter 1; UCP1, uncoupling protein 1; Dio2, deiodinase 2; ELOVL3, elongation of very long chain fatty acid-like 3 (fatty acid elongase 3); Cox8b, cytochrome C oxidase 8b; Prdm16, PR domain containing 16; Ebf2, early B-cell factor 2; Tle3, transducin-like enhancer of split 3; Gsta3, glutathione S-transferase alpha 3; Lyz2, lysozyme C-2 precursor; SREBP, sterol regulatory element-binding protein; PPAR, peroxisome proliferator-activated receptor; PGC, PPAR gamma coactivator; ChREBP, carbohydrate response element-binding protein; LXR, liver X receptor; CREB, cAMP response element-binding protein; 4EBP1, eukaryotic translation initiation factor 4E-binding protein 1; IR, insulin receptor; IRS, insulin receptor substrate; PI3K, phosphoinositol-4,5-bisphosphate 3-kinase; ERK, extracellular signal-regulated kinase; AMPK, 5’ adenosine monophosphate- activated protein kinase; TSC, tuberous sclerosis complex; mTOR, mammalian target of rapamycin; RAPTOR, regulatory-associated protein of mTOR.
RT-PCR, reverse transcriptase-polymerase chain reaction; siRNA, small interfering RNA; shRNA, short hairpin RNA; ELISA, enzyme-linked immunosorbent assay; FACS, fluorescence-activated cell sorting; ChIP, chromatin immunoprecipitation; RNAseq, RNA sequencing; ChIPseq, ChIP sequencing; ATP, adenosine triphosphate; MRI, magnetic resonance imaging; CRISPR/Cas9, clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9; cAMP, cyclic adenosine monophosphate; PER, proboscis extension response; AMPK, 5’ adenosine monophosphate-activated protein kinase.